Sage Journals: Discover world-class research

Retricted access

Case report

First published 2015-10

Fatal Stevens–Johnson syndrome/toxic epidermal necrolysis induced by allopurinol–rituximab–bendamustine therapy

Michael J Fallon, Jessica N Heck

Journal of Oncology Pharmacy Practice

Free access

Research article

First published 2013-6

Demographics,treatment patterns,safety,and real-world effectiveness in patients aged 70 years and over with chronic lymphocytic leukemia receiving bendamustine with or without rituximab: a retrospective study

Kathryn S. Kolibaba, James A. Sterchele, Avani D. Joshi [...]

Therapeutic Advances in Hematology

Open access

Case report

First published 2017

An unusual case of primary hepatic lymphoma with dramatic but unsustained response to bendamustine plus rituximab and literature review

Sih-Han Liao, Yin-Kai Chen, Shan-Chi Yu [...]

Sage Open Medical Case Reports

Open access

Case report

First published 2025

Blastoid Mantle Cell Lymphoma Presenting as an Isolated Cecal Mass

Lefika Bathobakae, Jorge L. Lopez Cuello, Rammy Bashir [...]

Journal of Investigative Medicine High Impact Case Reports

Open access

Review article

First published 2022

Treatment paradigm in Waldenström macroglobulinemia: frontline therapy and beyond

Saurabh Zanwar, Jithma P. Abeykoon

Therapeutic Advances in Hematology

Retricted access

Research article

First published 2012-10

Bendamustine and Rituximab (BR) Regimen for Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia

Jessica N. Lee, J. Aubrey Waddell, Dominic A. Solimando

Hospital Pharmacy

Open access

Review article

First published 2011

Bendamustine: Safety and Efficacy in the Management of Indolent Non-Hodgkins Lymphoma

Nishant Tageja

Clinical Medicine Insights: Oncology

Free access

Case report

First published 2012-7

Optimizing Premedications in the Prevention of Bendamustine Infusion-Related Reactions

Rebecca L. Tombleson, Viet Ho, Lubomir Sokol [...]

Cancer Control

Open access

Case report

First published 2018

A Novel Treatment With Obinutuzumab-Chlorambucil in a Patient With B-Cell Prolymphocytic Leukemia: A Case Report and Review of the Literature

Jason Hew, Dat Pham, Trevanne Matthews Hew [...]

Journal of Investigative Medicine High Impact Case Reports

Free access

Review article

First published 2016-4

Obinutuzumab for relapsed or refractory indolent non-Hodgkin’s lymphomas

Ludovic Gabellier, Guillaume Cartron

Therapeutic Advances in Hematology

Search results